Skip to main content
AUDEARA LIMITED logo

AUDEARA LIMITED — Investor Relations & Filings

Ticker · AUA ISIN · AU0000145807 LEI · 984500D8CD90E0BWE175 ASX Manufacturing
Open in API
Filings indexed 271 across all filing types
Latest filing 2026-05-14 Director's Dealing
Country AU Australia
Listing ASX AUA

About AUDEARA LIMITED

https://audeara.com

Audeara Limited specializes in the development of personalized audio solutions designed to enhance hearing health and sound clarity. The company’s primary offering consists of headphones integrated with proprietary software that performs a clinical-grade hearing test. This assessment generates a unique hearing profile, allowing the hardware to adjust sound frequencies in real-time to meet the specific auditory requirements of the user. By tailoring sound to individual hearing profiles, the technology aims to provide high-fidelity audio while minimizing the risk of further hearing degradation. These solutions are frequently implemented in clinical settings and by individuals seeking assistive listening devices that bridge the gap between traditional consumer electronics and medical hearing aids. The focus remains on delivering customized auditory experiences through innovative signal processing and user-centric design.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - David Trimboli 3 pages 289.8KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” reporting a director’s personal securities transactions and changes in holdings under Australian listing rule 3.19A.2. This is a classic insider dealing disclosure by a director. According to the classification definitions, reports of share transactions by directors are classified as Director’s Dealing (Code: DIRS).
2026-05-14 English
Transition of Chief Technology Officer 2 pages 273.7KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement dated 23 April 2026 describing the resignation of the Co-founder and Chief Technology Officer and the planned transition. It details changes in senior management (the CTO stepping down), includes quotes from the CEO and the departing executive, and is authorised by the Board. This fits the definition of a Board/Management Information announcement regarding changes in the company’s senior management.
2026-04-22 English
Audeara Secures Exclusive Deal with Shokz Health Global 4 pages 1.2MB
Regulatory Filings Classification · 75% confidence The document is an ASX market announcement describing a commercial distribution agreement with Shokz Health Global. It is not an earnings release, proxy, dividend notice, M&A bid, share issue, or management change. There is no attached detailed report or financial statements. It’s a general regulatory announcement about a partnership, which falls under the fallback category Regulatory Filings (RNS).
2026-04-15 English
Q3 FY26 Quarterly Activities Report & Appendix 4C 11 pages 660.3KB
Interim / Quarterly Report Classification · 95% confidence The document is an update for the three-month period ended 31 March 2026 (Q3 FY26) and includes detailed financial data such as cash flows from operating, investing, and financing activities, revenue figures, and management commentary. It also contains the Appendix 4C Quarterly cash flow report, which is a regulatory requirement for entities listed on the ASX under Listing Rule 4.7B. The document provides substantive financial data and analysis for a quarter, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2026-04-13 English
Application for quotation of securities - AUA 6 pages 18.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) form used for the application for quotation of securities. It details the issuance and quotation of securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue dates, and whether the securities are cash consideration or not. This type of filing is related to changes in the company's capital structure, specifically the issuance and quotation of new shares. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital change. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not merely an announcement of a report but a substantive filing about securities quotation.
2026-04-13 English
Auracast platform expansion underway with Clinico Inc 4 pages 382.2KB
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about purchase orders received by Audeara Limited for commercial programs involving Auracast-enabled devices and technology integration. It discusses product launches, commercial partnerships, sales channels, and strategic business updates. There are no financial statements, quarterly or annual results, regulatory certifications, or legal proceedings mentioned. The content focuses on business development and commercial progress rather than financial reporting or governance changes. This fits best under Capital/Financing Update (CAP) as it relates to commercial program commencements and sales growth potential, which are typical of capital or financing activity updates. The document length and detail also support it being a substantive update rather than a brief announcement or regulatory filing.
2026-03-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.